Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Master Transcription Regulators

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Metabolomics of healthy hematopoietic stem cells and leukemic stem cells.

Journal of clinical and translational research·2026

Same author

Selective targeting of RSK signaling with PMD-026 suppresses FLT3-activated acute myeloid leukemia while sparing normal hematopoiesis.

Leukemia·2026

Same author

Immunological mechanisms and therapeutic advances in chronic myeloid leukemia.

Leukemia·2026

Same author

Longitudinal Single-Cell RNA-Sequencing Reveals Evolution of Micro- and Macro-states in Chronic Myeloid Leukemia.

Cancer research·2026

Same author

DHODH as a targetable metabolic Achilles' heel for chemotherapy-resistant B-ALL.

Blood·2026

Same author

Inflammatory pathways and the bone marrow microenvironment in inherited bone marrow failure syndromes.

Stem cells (Dayton, Ohio)·2025

Search research articles

Related Experiment Video

Updated: Mar 18, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

CBP/p300 acetyltransferase activity in hematologic malignancies.

Ritika Dutta¹, Bruce Tiu¹, Kathleen M Sakamoto¹

¹Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.

Molecular Genetics and Metabolism

|July 7, 2016

Summary

CREB binding protein (CBP) and p300 regulate blood cell formation. Disrupting their function impairs blood cell development and renewal, potentially leading to hematologic cancers and offering new therapeutic targets.

Keywords:

CBP CREB-binding protein Hematologic malignancies Lysine acetyltransferase activity Targeted therapy p300

More Related Videos

Assays for Validating Histone Acetyltransferase Inhibitors

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

Related Experiment Videos

Last Updated: Mar 18, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Assays for Validating Histone Acetyltransferase Inhibitors

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

Area of Science:

Molecular Biology
Hematology
Cancer Biology

Background:

CREB binding protein (CBP) and p300 are crucial for hematopoiesis.
They act as transcriptional coactivators and acetyltransferases.
Loss of CBP/p300 function leads to hematopoietic deficiencies and stem cell disruption.

Purpose of the Study:

To investigate the role of CBP/p300 acetyltransferase activity in hematopoiesis.
To understand how disrupting this activity impacts blood cell development.
To explore potential therapeutic strategies for CBP/p300-related hematologic diseases.

Main Methods:

The abstract does not specify methods.
Further research would involve molecular and cellular assays.
In vivo and in vitro models of hematopoiesis and cancer.

Main Results:

The abstract does not specify results.
CBP/p300 dysfunction causes proliferation and differentiation defects.
Aberrant acetylation by CBP/p300 is linked to hematologic cancers.

Conclusions:

Understanding CBP/p300 acetyltransferase activity is key to treating hematologic diseases.
Targeting this activity could offer novel therapeutic avenues.
Further research is needed to elucidate specific mechanisms and therapeutic potential.